Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a vaccine therapy for stage IIB to stage IV melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED